DNA/RNA Sequencing is the fastest growing sector, North America is the largest market
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
This market expansion is primarily propelled by the escalating global demand for food security, the urgent imperative to develop climate-smart crops capable of withstanding extreme weather conditions, and the rapidly decreasing costs of DNA sequencing, which collectively democratize access to advanced breeding tools. However, a significant restraint on broader market expansion is the complex and fragmented regulatory landscape that varies considerably across regions, frequently delaying the commercialization of new products. Despite these hurdles, the sector exhibits immense economic potential, as evidenced by the U.S. bioeconomy's direct economic impact in food, agriculture, and manufacturing, valued at $210 billion in 2025, signaling the robust underlying economic value driving industry growth.
Market Drivers
Rapid technological advancements in next-generation sequencing and gene editing serve as the primary engines propelling the Global Agrigenomics Market, facilitating the precise modification of crop genomes to significantly enhance productivity, a shift reflected in the robust development pipelines of major industry players like BASF and the substantial revenue generated by sequencing tool providers such as Illumina. Concurrently, the increasing necessity for climate-resilient and disease-resistant crop varieties is accelerating market adoption, as farmers contend with increasingly volatile environmental conditions. Agrigenomics enables the swift identification and integration of genes responsible for traits like drought tolerance and pest resistance, thereby ensuring food security in a changing climate, a strategic expansion demonstrated by Corteva Agriscience's launch of approximately 2,000 new products over the past five years, aimed at mitigating yield losses from extreme weather and biological threats.Market Challenges
The intricate and fragmented global regulatory landscape acts as a significant impediment to the Global Agrigenomics Market, directly hindering the efficiency and speed of product commercialization. The disparity in regulatory frameworks across national borders forces companies to navigate a disjointed system, where a genomic trait approved in one region may be rejected or stalled in another.This lack of harmonization necessitates duplicative testing and documentation, diverting substantial capital from vital research and development. Consequently, the high financial burden of compliance creates a significant barrier to entry, often discouraging smaller biotechnology firms and concentrating innovation on major crops with guaranteed returns. These regulatory hurdles critically extend development timelines, often requiring over $100 million and a decade or more to commercialize a single new biotech plant product, thereby reducing immediate return on investment and severely limiting the sector's ability to dynamically respond to evolving environmental threats, ultimately restricting overall market expansion.
Market Trends
The integration of Artificial Intelligence and Machine Learning for predictive breeding is fundamentally reshaping the agrigenomics landscape, shifting the focus from mere data generation to high-precision predictive modeling. This technological convergence enables seed companies to utilize advanced algorithms to analyze vast genomic datasets and predict complex phenotypic traits, such as drought tolerance and nutrient use efficiency, with unprecedented accuracy, significantly shortening development cycles for new commercial varieties, as supported by substantial R&D investments from companies like Bayer Global. Concurrently, the application of genomic tools for livestock methane reduction and sustainability is emerging as a critical trend, driven by the global imperative to lower the environmental footprint of animal agriculture. Genomic selection is increasingly employed to identify and propagate animals with naturally lower methane emission profiles and superior feed conversion rates, allowing the livestock sector to meet stringent climate goals while maintaining profitability through scientifically validated genetic improvements, a segment evidenced by the robust market demand for advanced animal health and genetic solutions from companies like Zoetis.Key Market Players
- Illumina, Inc.
- Thermo Fischer Scientific, Inc.
- Agilent Technologies, Inc.
- Eurofins Scientific SE
- LGC Limited
- Tecan Genomics, Inc.
- Neogen Corporation
- Galseq Srl Via Italia
- Biogenetic Services' Inc.
Report Scope
In this report, the Global Agrigenomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Agrigenomics Market, by Purpose:
- DNA Extraction & Purification
- DNA/RNA Sequencing
- Genotyping
- Gene Expression Profiling
- GMO/Trait Purity Testing
- Others
Agrigenomics Market, by Sequencer Type:
- Sanger Sequencing
- Pacbio Sequencers
- Solid Sequencers
- Illumina HI SEQ Family
- Others
Agrigenomics Market, by Application:
- Livestock
- Crops
Agrigenomics Market, by Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Agrigenomics Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Illumina, Inc.
- Thermo Fischer Scientific, Inc.
- Agilent Technologies, Inc.
- Eurofins Scientific SE
- LGC Limited
- Tecan Genomics, Inc.
- Neogen Corporation
- Galseq Srl Via Italia
- Biogenetic Services' Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 177 |
| Published | May 2026 |
| Forecast Period | 2025 - 2031 |
| Estimated Market Value ( USD | $ 4.39 Billion |
| Forecasted Market Value ( USD | $ 7.37 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |


